| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/21/2006 | CA2186224C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/16/2006 | WO2006017842A1 Compounds for proteasome enzyme inhibition |
| 02/16/2006 | WO2005116068A8 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 02/16/2006 | WO2004007529A3 Iap binding compounds |
| 02/16/2006 | US20060036073 Neurotrophic and neuroprotective peptides |
| 02/16/2006 | US20060036071 Processes for preparing eptifibatide |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035820 Fungicides trans 1-[4-[(2-aminocyclo-hexyl)-amino]N2-[[4''(pentyloxy)[1,1':4', 1''-terphenyl]-4-yl-carbonyl]-L-ornithine]-4-[4(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandine B trifluoroacetate; treating infections caused by Candida, Aspergillus, Cryptococcus |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060034836 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 02/16/2006 | CA2589765A1 Compounds for proteasome enzyme inhibition |
| 02/16/2006 | CA2571407A1 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 02/15/2006 | EP1625153A1 Acylated lysobactin-type nonadepsipeptides |
| 02/15/2006 | EP1625149A2 Method and carrier complexes for delivering molecules to cells |
| 02/15/2006 | EP1625148A1 Peptide complex |
| 02/15/2006 | EP1625122A1 Dipeptidyl peptidase inhibitors |
| 02/15/2006 | EP1624897A2 Hiv prodrugs cleavable by cd26 |
| 02/15/2006 | EP1624885A2 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 02/15/2006 | EP1399468B1 2-((n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl)-amino)-alkylboronic acid derivatives |
| 02/15/2006 | CN1735426A Peptides as solubilizing excipients for transforming growth factor ss proteins |
| 02/15/2006 | CN1735422A Pept¿¼deos antimicrobianos de novispirin |
| 02/15/2006 | CN1242052C Biological pure culture for Nocardia |
| 02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 02/14/2006 | US6998398 use in improvement of gastrointestinal blood flow, in treatment of hypertension and in treatment and prophylaxis of cardiac damages induced by adriamycin and comparable anti-cancer drugs |
| 02/14/2006 | CA2336597C Hepatitis c inhibitor peptides |
| 02/14/2006 | CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 02/09/2006 | WO2006014552A2 Cyclic peptides for treatment of cachexia |
| 02/09/2006 | US20060030699 Reaction product of thioctic acid and tris(aminoanilinocarbonylalkyl)methylaminocarbonylalkylamine or N,N-bis{N,N-bis(aminobenzoylaminoalkyl)aminocarbonylalkyl}aminoalkanoamide; reaction product with an oligosaccharide; immobilized on support to form sensor chip used for surface plasmon resonance |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030533 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 02/09/2006 | US20060029638 Methods for treating body tissue |
| 02/09/2006 | US20060029545 Metal radionuclide complexed directly to a an annexin that has been modified to add a sulfhydryl group which participates in the complexation of the metal radionuclide; useful for imaging vascular thrombi |
| 02/09/2006 | CA2570321A1 Inhibitors of iap |
| 02/08/2006 | EP1623036A2 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2006 | EP1622565A2 Method for inhibiting cellular activation by insulin-like growth factor-1 |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/08/2006 | CN1732016A Modified cytokines for use in cancer therapy |
| 02/08/2006 | CN1731934A Ace inhibitory peptides from plant materials |
| 02/08/2006 | CN1240712C Method of preparing tyrosine-serine-leucine tripeptide |
| 02/08/2006 | CN1240711C Novel peptide having angiotensin convertase inhibitory effect |
| 02/08/2006 | CN1240710C Method for preparing bicyclic compounds and use of said method for preparing inhibitor compound |
| 02/07/2006 | US6995238 Cyclopeptide derivatives |
| 02/07/2006 | US6995177 HCV NS3 protease inhibitors |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/07/2006 | US6995135 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 02/02/2006 | WO2005090387A3 Histone h2a peptide derivatives and analogs and methods of use thereof |
| 02/02/2006 | US20060025578 Chemical synthesis of reagents for peptide coupling |
| 02/02/2006 | US20060025569 Microwave-assisted peptide synthesis |
| 02/02/2006 | US20060025568 Microwave-assisted peptide synthesis |
| 02/02/2006 | US20060025567 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 02/02/2006 | US20060025566 Macrocyclic modulators of the ghrelin receptor |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025347 IAP binding compounds |
| 02/02/2006 | US20060025345 Substituted ethane-1,2-diamines for the treatment of Alzheimer's disease |
| 02/02/2006 | US20060024730 TF binding compounds |
| 02/01/2006 | EP1621546A1 Peptide ligands specific to immonoglobulins |
| 02/01/2006 | EP1620458A2 SYNTHESIS OF N- [N-(3,3-DIMETHYLBUTYL)-L-a-ASPARTYL] -L-PHENYLALANINE 1-METHYL ESTER USING 3,3-DIMETHYLBUTYRALDEHYDE PRECURSORS |
| 02/01/2006 | EP1620456A2 Hla-a2 tumor associated antigen peptides and compositions |
| 02/01/2006 | EP1620130A1 Prodrugs cleavable by cd26 |
| 02/01/2006 | EP1620090A1 Pyrazole compounds as hsp90 inhibitors for the treatment of cancer |
| 02/01/2006 | EP1619957A1 Hydrolysed casein product comprising tripeptides ipp and/ or vpp |
| 02/01/2006 | EP1485406A4 Highly homogeneous molecular markers for electrophoresis |
| 02/01/2006 | EP1465907A4 Modular peptide-based reagent |
| 02/01/2006 | EP1100928B1 Bifunctional enzymes for biopolymer production |
| 01/31/2006 | US6992207 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 01/31/2006 | US6992105 N-[2-[(S)-2-Acetylthio-3-methylbutanoylamino]-2-methylpropionyl]-O-ben-zyl-L-serine Ethyl; inhibitors of angiotensin converting enzyme, neutral endopeptidase, endothelin converting enzyme. |
| 01/31/2006 | US6992081 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 01/31/2006 | US6992064 Central nervous system disorders; antidepressants |
| 01/31/2006 | US6992063 Compositions and method for regulating apoptosis |
| 01/31/2006 | US6991775 Peptide-based multimeric targeted contrast agents |
| 01/26/2006 | WO2006009645A1 Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | WO2005066197A3 Inhibitors of methionine aminopeptidase-2 and uses thereof |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019905 Hepatitis C inhibitor peptide analogs |
| 01/26/2006 | US20060019901 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 01/26/2006 | US20060019900 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 01/26/2006 | CA2579726A1 Macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | CA2571237A1 Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | CA2567982A1 P4has as modifiers of the igfr pathway and methods of use |
| 01/25/2006 | EP1619201A1 Novel glycopeptide or peptide capable of imparting rich taste and method of imparting rich taste to food therewith |
| 01/25/2006 | EP1618380A2 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION |
| 01/25/2006 | EP1618125A1 Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same |
| 01/25/2006 | EP1618106A2 Carbacephem -lactam antibiotics |
| 01/25/2006 | EP1494695A4 Plasma protein-binding ligands |
| 01/25/2006 | EP1474430B1 Bi-functionalised metallocenes use for marking biological molecules |
| 01/25/2006 | CN1726069A Production of crystalline materials by using high intensity ultrasound |
| 01/25/2006 | CN1238371C Technetium and rhenium coupled tri-and tetrapeptide combinational library, its active peptide compound and its foundation method |
| 01/24/2006 | US6989452 Anticancer agents |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/23/2006 | CA2586086A1 Furin inhibitors |
| 01/19/2006 | WO2005056576A3 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/19/2006 | US20060014966 Cell adhesion inhibitors |
| 01/19/2006 | US20060014929 Liquid phase peptide synthesis of KL-4 pulmonary surfactant |
| 01/19/2006 | US20060014926 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |